Investing Snacks4h
Gardasil Gamble: Merck’s Vaccine Blunder in China
Bernstein Liebhard LLP reminds Merck investors of an April 14, 2025 deadline to join a securities fraud class action lawsuit.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
New York, New York-- (Newsfile Corp. - April 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, ...
ROSEN, A RANKED AND LEADING FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and ...
Snopes.com2d
Snopes Homepage
Police charged the 24-year-old woman with counts related to improper disposal and notification of a dead body. Written by: April 1, 2025 Despite misleading YouTube videos, U.S. President Donald ...
Is Merck Stock a Bargain Buy?
Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...
Big pharma faces headwinds in China as vaccine sales decline
Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
Merck & Co.: Looming Patent Expiries For Key Drugs Weaken Longer-Term Outlook
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.